Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

185 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Current status of anticoagulants].
Oger E, Mottier D. Oger E, et al. Presse Med. 2000 May 27-Jun 3;29(19):1079-82. Presse Med. 2000. PMID: 10874921 French.
Hormone replacement therapy and circulating ICAM-1 in postmenopausal women--a randomised controlled trial.
Scarabin PY, Alhenc-Gelas M, Oger E, Plu-Bureau G. Scarabin PY, et al. Among authors: oger e. Thromb Haemost. 1999 May;81(5):673-5. Thromb Haemost. 1999. PMID: 10365734 Clinical Trial.
Clinical usefulness of D-dimer tests in excluding pulmonary embolism is highly dependent upon age.
Mottier D, Couturaud F, Oger E, Leroyer C. Mottier D, et al. Among authors: oger e. Thromb Haemost. 1998 Sep;80(3):527. Thromb Haemost. 1998. PMID: 9759644 No abstract available.
Underweight is associated with a reduced risk of venous thromboembolism. Results from the EDITH case-control study.
Delluc A, Mottier D, Le Gal G, Oger E, Lacut K. Delluc A, et al. Among authors: oger e. J Thromb Haemost. 2009 Apr;7(4):728-9. doi: 10.1111/j.1538-7836.2009.03280.x. Epub 2009 Jan 13. J Thromb Haemost. 2009. PMID: 19192117 No abstract available.
Prevalence of the JAK2 V617F mutation is low among unselected patients with a first episode of unprovoked venous thromboembolism.
Ugo V, Le Gal G, Lecucq L, Mottier D, Oger E; EDITH Collaborative Study Group. Ugo V, et al. Among authors: oger e. J Thromb Haemost. 2008 Jan;6(1):203-5. doi: 10.1111/j.1538-7836.2007.02811.x. Epub 2007 Oct 22. J Thromb Haemost. 2008. PMID: 17949475 No abstract available.
Estimation of a potentially preventable fraction of venous thromboembolism: a community-based prospective study.
Noboa S, Mottier D, Oger E; EPI-GETBO Study Group. Noboa S, et al. Among authors: oger e. J Thromb Haemost. 2006 Dec;4(12):2720-2. doi: 10.1111/j.1538-7836.2006.02196.x. J Thromb Haemost. 2006. PMID: 17100657 No abstract available.
Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: results from the EDITH Study.
Lacut K, Larramendy-Gozalo C, Le Gal G, Duchemin J, Mercier B, Gourhant L, Mottier D, Becquemont L, Oger E, Verstuyft C. Lacut K, et al. Among authors: oger e. J Thromb Haemost. 2007 Oct;5(10):2020-4. doi: 10.1111/j.1538-7836.2007.02706.x. J Thromb Haemost. 2007. PMID: 17883698
Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case-control study.
Lacut K, Le Gal G, Couturaud F, Cornily G, Leroyer C, Mottier D, Oger E. Lacut K, et al. Among authors: oger e. Fundam Clin Pharmacol. 2007 Dec;21(6):643-50. doi: 10.1111/j.1472-8206.2007.00515.x. Fundam Clin Pharmacol. 2007. PMID: 18034665
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
Canonico M, Oger E, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; EStrogen and THromboEmbolism Risk (ESTHER) Study Group. Canonico M, et al. Among authors: oger e. J Thromb Haemost. 2006 Jun;4(6):1259-65. doi: 10.1111/j.1538-7836.2006.01933.x. J Thromb Haemost. 2006. PMID: 16706969
185 results
Jump to page
Feedback